PIGQ Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role of PIGQ

PIGQ (Phosphatidylinositol Glycan Anchor Biosynthesis, Class Q) is a critical component of the GPI transamidase complex, which facilitates the attachment of glycosylphosphatidylinositol (GPI) anchors to proteins. These anchors enable membrane protein localization and cellular signaling .

Overview of PIGQ Antibody, HRP Conjugated

The PIGQ Antibody, HRP conjugated, is a polyclonal antibody raised against a synthetic peptide corresponding to the N-terminal region of human PIGQ. It is covalently linked to horseradish peroxidase (HRP), enabling enzymatic signal amplification in immunoassays .

Enhanced Conjugation Methodology

A modified HRP-antibody conjugation protocol involving lyophilization (freeze-drying) of activated HRP significantly increases the enzyme-to-antibody ratio. This method improves ELISA sensitivity by up to 200-fold compared to classical methods, enabling antigen detection at concentrations as low as 1.5 ng/mL .

Functional Validation

  • Western Blot: Detects PIGQ at ~70 kDa under reducing conditions .

  • ELISA: Demonstrates high specificity for recombinant PIGQ with minimal cross-reactivity to unrelated proteins .

  • Immunohistochemistry: Localizes PIGQ in paraffin-embedded tissues with high resolution .

Comparative Analysis of HRP Conjugation Techniques

MethodSensitivity (ELISA)HRP-to-Antibody RatioStability
Classical Periodate1:25 dilution1:112 months
Lyophilized HRP 1:5,000 dilution2:160 months
AuNP-HRP Probes 10-fold increase4–5:16 months

Quality Control and Performance Metrics

  • Purity: >95% (Protein G-purified) .

  • Cross-Reactivity: <5% with non-target species (e.g., bovine, canine) .

  • Catalytic Activity: Retains >90% enzymatic function after lyophilization, confirmed by TMB substrate conversion in ELISA .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Orders are typically dispatched within 1-3 business days of receipt. Delivery times may vary depending on the order fulfillment method and destination. Please contact your local distributor for precise delivery estimates.
Synonyms
PIGQ; GPI1; Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q; N-acetylglucosamyl transferase component GPI1; Phosphatidylinositol-glycan biosynthesis class Q protein; PIG-Q
Target Names
PIGQ
Uniprot No.

Target Background

Function

This antibody targets a component of the glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex. This complex catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol, representing the initial step in GPI biosynthesis.

Gene References Into Functions

Relevant genetic studies highlight the importance of PIGQ:

  1. Genome-wide association studies identified PIGQ as a suggestive locus associated with Alzheimer's disease progression. (PMID: 25114068)[Link]
  2. PIGQ has been identified as a novel gene associated with Ohtahara Syndrome. (PMID: 24463883)[Link]
Database Links

HGNC: 14135

OMIM: 605754

KEGG: hsa:9091

STRING: 9606.ENSP00000026218

UniGene: Hs.741878

Protein Families
PIGQ family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is a Pig IgG HRP-conjugated antibody and what makes it useful in research applications?

Pig IgG HRP-conjugated antibodies are secondary antibodies that specifically recognize porcine immunoglobulin G (IgG) and are chemically linked to horseradish peroxidase (HRP) enzyme. These antibodies are critical research tools that exploit the high specificity of antibody-antigen binding coupled with the enzymatic amplification properties of HRP.

Immunoglobulin G represents the most abundant antibody isotype with serum concentrations typically ranging from 7.5-22 mg/ml and a molecular weight of approximately 150kDa. The core functions of IgG include neutralization of pathogens, opsonization to facilitate phagocytosis, complement fixation, and antibody-dependent cell-mediated cytotoxicity (ADCC). When studying porcine models or porcine-derived substances, these antibodies provide exceptional sensitivity and specificity .

The HRP conjugation allows for enzymatic signal amplification when appropriate substrates are introduced, enabling visualization or quantification of target molecules even at very low concentrations. This makes HRP-conjugated antibodies particularly valuable for detection methods requiring high sensitivity across multiple experimental platforms.

What are the primary applications for HRP-conjugated anti-pig IgG antibodies?

HRP-conjugated anti-pig IgG antibodies serve multiple critical functions across various immunological detection techniques:

  • ELISA (Enzyme-Linked Immunosorbent Assay): These antibodies function as detection reagents in sandwich or indirect ELISA formats to quantify porcine antibodies or antigens with high sensitivity .

  • Western Blotting (WB): They enable visualization of pig IgG or pig-specific antibody reactions on protein blots through enzymatic conversion of chemiluminescent or chromogenic substrates .

  • Immunohistochemistry (IHC): These conjugates allow for localization and visualization of antigens in tissue sections, providing spatial context to protein expression and distribution .

  • Immunochromatography: HRP-conjugated antibodies can be employed in lateral flow assays or strip tests for rapid detection applications, similar to the principle demonstrated in antibody conjugation check kits .

Each application requires specific optimization of antibody dilution and detection conditions to achieve optimal signal-to-noise ratios. Researchers should determine optimal working dilutions for their specific experimental system through titration experiments.

How should HRP-conjugated antibodies be stored to maintain optimal activity?

Proper storage is essential for preserving the functional activity of HRP-conjugated antibodies. The following guidelines should be observed:

  • Short-term storage: Store at 4°C for immediate or near-future use (typically up to 1-2 weeks). This temperature maintains antibody structure while minimizing enzymatic activity that could lead to self-degradation .

  • Long-term storage: Aliquot and store at temperatures below -20°C. Division into single-use aliquots is crucial to avoid repeated freeze-thaw cycles that can significantly reduce antibody activity .

  • Freeze-thaw cycles: These should be strictly minimized as each cycle can reduce activity. Products should never undergo more than 3-5 freeze-thaw cycles for reliable results .

  • Stability period: Under optimal storage conditions, most HRP-conjugated antibodies maintain their activity for approximately 60 months (5 years) when stored properly at temperatures below -20°C .

  • Transportation considerations: HRP-conjugated antibodies can typically be shipped on ice packs at ambient temperature for short periods without significant loss of activity .

Following manufacturer-specific guidelines is always recommended, as formulation details may vary between suppliers.

How can researchers confirm successful HRP conjugation to antibodies?

Verification of successful HRP conjugation is a critical quality control step. Several methods can be employed:

  • Immunochromatography strip test: Specialized kits utilize nitrocellulose membranes containing immobilized Protein A and Protein G that bind to the Fc region of IgG molecules. When the HRP-antibody conjugate is applied to the strip, it binds to these proteins. Adding HRP detection solution results in a visible line, confirming successful conjugation .

  • Functional assay: Testing the conjugate in its intended application (ELISA, WB, or IHC) using appropriate positive controls. Successful detection indicates functional conjugation .

  • Spectrophotometric analysis: Measuring absorbance at characteristic wavelengths for both protein (280nm) and HRP (403nm) to calculate the conjugation ratio.

For the immunochromatography method, the procedure involves:

  • Diluting the conjugate in running buffer containing 0.01% BSA

  • Applying the diluted conjugate to the test strip

  • Allowing 10 minutes for development

  • Observing for a visible line at the test position

Optimal dilution ranges for detection typically fall between 10 ng/mL to 0.5 ng/mL of conjugate, making this a sensitive verification method .

What controls should be included when using HRP-conjugated secondary antibodies?

Robust experimental design requires appropriate controls to ensure reliable results and proper interpretation:

  • Primary antibody controls:

    • Positive control: Known positive sample for target antigen

    • Negative control: Sample known to lack target antigen

    • Isotype control: Non-specific primary antibody of same isotype and concentration

  • Secondary antibody controls:

    • Secondary-only control: Omit primary antibody to assess non-specific binding

    • Background control: Complete omission of both primary and secondary antibodies

  • Substrate controls:

    • Substrate-only control: Assesses non-enzymatic substrate conversion

    • Quenching control: Validates the stopping reaction in ELISA applications

  • Cross-reactivity controls:

    • Test secondary antibody against potential cross-reactive species-specific antibodies

    • This is particularly important when working with samples containing multiple species' antibodies

For Western blot applications specifically, controls showing detection of known molecular weight markers with anti-pig IgG HRP-conjugated antibodies provide validation of both specificity and sensitivity, as demonstrated in applications using anti-goat IgG HRP-conjugated antibodies .

What is the optimal working concentration range for HRP-conjugated anti-pig IgG antibodies?

Determining the optimal working concentration requires balancing sensitivity with specificity:

  • Western blot applications: Typical dilution ranges of 1:1000 to 1:5000 from a 1 mg/mL stock solution are common starting points, similar to those used for anti-goat IgG HRP-conjugated antibodies in Western blot protocols .

  • ELISA applications: Often require higher dilutions, typically in the range of 1:5000 to 1:20,000 from a 1 mg/mL stock.

  • Immunohistochemistry: Generally employs dilutions in the range of 1:100 to 1:500 from a 1 mg/mL stock concentration.

  • Confirmation tests: For conjugation verification purposes, concentrations ranging from 10 ng/mL to 0.5 ng/mL are recommended for optimal signal detection in strip tests .

The optimal concentration should always be determined empirically for each specific application and experimental system. Serial dilution experiments are recommended to establish the optimal signal-to-noise ratio for new experimental setups or when changing any assay parameters .

How do different fixation methods affect the performance of HRP-conjugated antibodies in immunohistochemistry?

Fixation methods can significantly impact epitope accessibility and antibody binding efficiency:

  • Paraformaldehyde/formalin fixation:

    • Preserves morphology but may mask epitopes through protein cross-linking

    • May require antigen retrieval methods (heat-induced or enzymatic) to expose epitopes

    • Generally provides good structural preservation for HRP-based detection systems

  • Methanol/acetone fixation:

    • Preserves many antigens but can disrupt membrane structures

    • Often eliminates need for separate permeabilization step

    • May yield higher background with some HRP-conjugated antibodies due to increased permeability

  • Glutaraldehyde fixation:

    • Creates stronger cross-links than formaldehyde

    • May require more aggressive antigen retrieval

    • Can cause higher autofluorescence that may interfere with some detection methods

  • Fresh-frozen sections:

    • Minimal epitope masking but poorer morphological preservation

    • Often provides superior antibody accessibility

    • May require modified blocking protocols to reduce background

For optimal results with HRP-conjugated anti-pig IgG antibodies, pilot experiments comparing multiple fixation methods are recommended when establishing new protocols. The method providing the best balance between morphological preservation and specific signal should be selected.

What strategies can improve signal-to-noise ratio when using HRP-conjugated antibodies in Western blots?

Optimizing Western blot protocols with HRP-conjugated antibodies involves several critical considerations:

  • Blocking optimization:

    • Use 3-5% BSA or milk in TBS-T/PBS-T, selecting the blocking agent least likely to cross-react

    • Consider specialized blocking reagents for problematic applications

    • Extend blocking time to 1-2 hours at room temperature or overnight at 4°C for reduced background

  • Antibody dilution and incubation:

    • Test multiple antibody dilutions to find optimal concentration

    • Incubate antibodies in fresh blocking solution

    • Consider longer incubation at 4°C rather than shorter at room temperature

  • Washing protocols:

    • Increase wash duration and frequency (5-6 washes of 5-10 minutes each)

    • Include higher salt concentration (up to 500mM NaCl) in wash buffers to reduce non-specific ionic interactions

    • Consider adding low concentrations of detergents (0.05-0.1% Tween-20) to reduce hydrophobic interactions

  • Detection optimization:

    • Select detection chemistry appropriate for expected signal strength

    • Enhanced chemiluminescence (ECL) substrates offer various sensitivity levels

    • Consider exposure time optimization or digital imaging with multiple acquisition times

When troubleshooting Western blots using anti-pig IgG HRP-conjugated antibodies, systematic modification of one variable at a time is recommended to identify the specific factors affecting performance.

What are the key differences to consider when selecting between polyclonal and monoclonal HRP-conjugated anti-pig IgG antibodies?

The choice between polyclonal and monoclonal antibodies has significant implications for experimental outcomes:

CharacteristicPolyclonal HRP-Conjugated AntibodiesMonoclonal HRP-Conjugated Antibodies
Epitope RecognitionRecognize multiple epitopes on the target antigenRecognize a single epitope on the target antigen
SensitivityGenerally higher sensitivity due to binding multiple epitopesMay have lower sensitivity but greater specificity
Batch VariationHigher lot-to-lot variationLower lot-to-lot variation
Cross-ReactivityPotentially higher risk of cross-reactivityTypically lower cross-reactivity
ApplicationsExcellent for detection of native proteins and denatured proteinsMay be less effective if target epitope is sensitive to denaturation
Signal StrengthOften stronger signal due to multiple binding sitesMay require signal amplification for weaker signals
ProductionDerived from multiple B cell lineages in immunized animalsProduced from single B cell clone
CostGenerally less expensiveTypically more expensive

How can consistent batch-to-batch variation be addressed when working with HRP-conjugated antibodies?

Ensuring experimental reproducibility across different antibody lots presents significant challenges:

  • Validation protocols:

    • Implement standardized validation procedures for each new antibody lot

    • Directly compare new lots with previously validated lots using identical samples

    • Establish acceptance criteria for lot-to-lot variation

  • Reference standards:

    • Maintain internal reference standards for critical applications

    • Create standard curves with each antibody lot to normalize results

    • Consider using pooled positive controls that can be prepared in bulk and stored

  • Documentation practices:

    • Record lot numbers and preparation dates for all antibodies

    • Document detailed protocols including antibody dilutions and incubation conditions

    • Maintain databases correlating experimental outcomes with specific antibody lots

  • Purchasing strategies:

    • Purchase larger quantities of validated lots when possible

    • Consider reserving specific lots for critical experiments

    • Discuss batch consistency requirements with suppliers

  • Technical adjustments:

    • Adjust antibody concentrations based on lot-specific activity

    • Modify incubation times to achieve comparable results

    • Standardize detection and quantification methods across experiments

For projects requiring long-term reproducibility, researchers should consider creating detailed validation standards and maintaining reference materials for cross-batch calibration.

What are common causes of non-specific background when using HRP-conjugated antibodies, and how can they be mitigated?

Non-specific background can significantly impact data quality and interpretation:

  • Inadequate blocking:

    • Solution: Increase blocking agent concentration (3-5% BSA or milk)

    • Extend blocking time to 1-2 hours at room temperature or overnight at 4°C

    • Consider alternative blocking agents (commercial blocking buffers, fish gelatin, etc.)

  • Excessive antibody concentration:

    • Solution: Titrate antibodies to determine optimal working dilution

    • Start with manufacturer recommendations and adjust based on signal-to-noise ratio

    • Consider longer incubation with more dilute antibody solution

  • Insufficient washing:

    • Solution: Increase number and duration of wash steps

    • Use larger volumes of wash buffer

    • Add detergents or increase salt concentration in wash buffers

  • Cross-reactivity issues:

    • Solution: Pre-absorb secondary antibodies against potentially cross-reactive proteins

    • Select antibodies specifically tested against relevant species

    • Use highly purified antibody preparations (>90% purity by SDS-PAGE)

  • Sample-specific issues:

    • Solution: Treat samples to remove interfering substances

    • Consider alternative sample preparation methods

    • Include appropriate sample-specific blocking agents

For HRP-conjugated anti-pig IgG antibodies specifically, using affinity-purified preparations with confirmed purity (>90% by SDS-PAGE) can significantly reduce background issues .

How should researchers approach troubleshooting weak or absent signals when using HRP-conjugated antibodies?

Systematic troubleshooting approach for weak or absent signals:

  • Antibody activity verification:

    • Test antibody functionality using positive control samples

    • Verify HRP enzyme activity using direct enzyme assays

    • Confirm successful HRP conjugation using methods like immunochromatography strip tests

  • Protocol optimization:

    • Decrease antibody dilution (use higher concentration)

    • Extend incubation times for both primary and secondary antibodies

    • Increase sample concentration when possible

  • Detection system assessment:

    • Switch to more sensitive detection substrates (enhanced chemiluminescence)

    • Increase substrate incubation time

    • Verify substrate freshness and proper storage

  • Sample preparation evaluation:

    • Assess protein denaturation conditions for Western blots

    • Review antigen retrieval methods for IHC

    • Consider native vs. denatured protein detection requirements

  • Storage and handling audit:

    • Verify proper antibody storage conditions (4°C short-term, <-20°C long-term)

    • Minimize freeze-thaw cycles that may reduce activity

    • Check for visible precipitation or contamination in antibody solutions

When troubleshooting HRP-conjugated anti-pig IgG antibodies specifically, verifying format (sterile filtered solution in PBS, pH 7.2) and absence of interfering additives can help identify potential sources of reduced activity .

What methodological considerations are important when using HRP-conjugated antibodies across different species and sample types?

Cross-species applications require careful consideration:

  • Species cross-reactivity assessment:

    • Review documented cross-reactivity profiles

    • Perform pre-absorption against potentially cross-reactive species

    • Include appropriate negative controls from non-target species

  • Epitope conservation analysis:

    • Consider evolutionary conservation of target epitopes across species

    • Review literature for validated cross-species applications

    • Perform sequence alignment to predict potential cross-reactivity

  • Sample type considerations:

    • Adjust protocols based on sample type (cell lysates, tissue sections, bodily fluids)

    • Modify extraction and preparation methods to preserve target epitopes

    • Consider matrix effects that may interfere with antibody binding

  • Detection system compatibility:

    • Ensure detection chemistry is compatible with sample buffers and components

    • Address potential interference from endogenous peroxidases

    • Consider alternative detection systems for problematic samples

  • Validation requirements:

    • Establish species-specific positive and negative controls

    • Validate antibodies independently for each species and sample type

    • Document specific protocol modifications required for cross-species applications

For anti-pig IgG HRP-conjugated antibodies with documented porcine specificity, careful validation is required when considering applications involving related species .

How can HRP-conjugated antibodies be effectively employed in multiplex detection systems?

Multiplexing with HRP-conjugated antibodies requires strategic approaches:

  • Sequential detection methods:

    • Perform multiple rounds of detection with stripping between each round

    • Use carefully optimized stripping protocols to remove previous antibodies without damaging sample

    • Validate complete removal of previous detection antibodies before applying subsequent ones

  • Spatial separation approaches:

    • Design assays with physically separated detection zones

    • Employ microfluidic systems for compartmentalized reactions

    • Utilize printed microarrays with spatially resolved detection areas

  • Signal discrimination techniques:

    • Use substrates producing differently colored precipitates

    • Employ digital imaging with spectral unmixing

    • Consider combining HRP with other enzyme systems (alkaline phosphatase, β-galactosidase)

  • Technological integration:

    • Combine with fluorescent detection systems in sequential or parallel workflows

    • Consider tyramide signal amplification for improved sensitivity and localization

    • Integrate with automated imaging systems for high-throughput applications

For complex experimental designs, preliminary validation of individual detection steps should precede multiplex implementation to ensure each component functions as expected.

What considerations are important when using HRP-conjugated antibodies in automated immunoassay platforms?

Automation presents unique challenges and opportunities:

  • Antibody stability factors:

    • Ensure antibody stability at ambient temperature during automated processing

    • Consider addition of stabilizers for prolonged instrument runs

    • Validate performance after extended storage in automated systems

  • Dilution and mixing parameters:

    • Optimize automated dilution protocols to ensure proper concentration

    • Validate mixing efficiency to prevent concentration gradients

    • Consider dead volumes in fluid handling systems

  • Timing and incubation variables:

    • Adjust incubation times to accommodate instrument constraints

    • Validate temperature control for consistent reaction kinetics

    • Implement quality control steps to monitor reaction progression

  • Washing efficiency:

    • Optimize automated washing steps for complete removal of unbound antibodies

    • Validate washing efficiency through background measurement

    • Consider additional washing cycles for problematic samples

  • Detection system compatibility:

    • Ensure detector sensitivity matches expected signal range

    • Validate linear response range of detection system

    • Implement internal calibration controls for system performance

When adapting manual protocols for HRP-conjugated anti-pig IgG antibodies to automated platforms, systematic comparison studies should be performed to establish equivalence of results.

How can researchers effectively conjugate HRP to custom antibodies when commercial options are unavailable?

Custom conjugation approaches for specialized applications:

  • Chemical conjugation methods:

    • Periodate oxidation: Creates aldehyde groups on HRP glycoproteins that react with primary amines on antibodies

    • Glutaraldehyde: Forms crosslinks between HRP and antibody proteins

    • Maleimide activation: Targets sulfhydryl groups for specific conjugation

  • Protocol considerations:

    • Protein concentration: Typically 1-10 mg/mL for optimal conjugation

    • Buffer selection: Avoid amines (Tris) and sulfhydryls during conjugation

    • pH optimization: Usually between 7.0-8.5 for maximal efficiency

  • Conjugation verification:

    • Use HRP conjugation check kits to confirm successful linkage

    • Test functional activity in target applications

    • Measure protein:enzyme ratios spectrophotometrically

  • Purification approaches:

    • Size exclusion chromatography to separate conjugated product from unreacted components

    • Affinity purification using protein A/G for antibody-specific isolation

    • Consider concentration and buffer exchange to final storage formulation

  • Storage recommendations:

    • Formulate in PBS pH 7.2 without additional additives for maximum compatibility

    • Aliquot and store at <-20°C for long-term stability

    • Validate stability through periodic activity testing

For researchers needing to prepare custom HRP-conjugated anti-pig IgG antibodies, commercial conjugation kits with validation systems provide the most reliable approach for consistent results.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.